Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study - ARMYDA-AMULET

NCT05554822 is registered in ClinicalTrials.gov with Azienda Ospedaliero Universitaria Maggiore della Carita as lead sponsor.

NCT NCT05554822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05554822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study - ARMYDA-AMULET
Lead sponsor
Azienda Ospedaliero Universitaria Maggiore della Carita
Phase
Phase 3
Overall status
Unknown status
Start date
June 14, 2021
Completion date
December 31, 2023
Enrollment
574 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

antiplatelet therapy, left atrial appendage occlusion